#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12584	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2129	588.5	0	.	n	.	0	A69G	SNP	69	69	A	387	387	G	748	G,A	666,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12584	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2129	588.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1768	1768	T	730	T	645	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12584	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2129	588.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1502	1502	C	741	C	661	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23116	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	649.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1714	1714	A	788	A	713	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23116	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	649.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2348	2348	C	804	C	714	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23116	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	649.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2422	2422	A	723	A	663	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23116	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	649.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2974	2974	C	767	C,G	689,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	1898	folP	852	852	99.77	folP.l15.c4.ctg.1	1380	136.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	709	711	AAA	188;187;189	A,C;A;A	170,1;170;174	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	1898	folP	852	852	99.77	folP.l15.c4.ctg.1	1380	136.5	0	.	p	.	0	V275M	NONSYN	823	825	GTG	1081	1083	ATG	162;162;161	A,C;T;G	145,1;147;145	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	1898	folP	852	852	99.77	folP.l15.c4.ctg.1	1380	136.5	1	SNP	p	R228S	1	.	.	682	684	AGC	940	942	AGC	193;191;193	A;G;C	175;175;177	folP.WHO_W_01420c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4852	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3447	140.4	1	SNP	p	S91F	0	.	.	271	273	TCC	625	627	TCC	169;167;170	T;C;C	150;151;151	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4852	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3447	140.4	1	SNP	p	D95N	0	.	.	283	285	GAC	637	639	GAC	171;170;170	G;A;C	156;153;152	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4852	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3447	140.4	1	SNP	p	D95G	0	.	.	283	285	GAC	637	639	GAC	171;170;170	G;A;C	156;153;152	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1474	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1298	113.0	0	.	p	.	0	F178L	NONSYN	532	534	TTC	856	858	CTC	137;139;138	C;T;C	124;131;126	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1474	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1298	113.0	1	SNP	p	G45D	0	.	.	133	135	GGC	457	459	GGC	193;195;194	G;G;C,T	172;175;171,1	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	740	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1070	68.7	0	.	n	.	0	A197.	DEL	197	197	A	632	632	A	190	A	165	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4560	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2998	151.9	1	SNP	p	D86N	0	.	.	256	258	GAC	603	605	GAC	231;233;234	G;A;C	202;204;203	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4560	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2998	151.9	1	SNP	p	S87I	0	.	.	259	261	AGT	606	608	AGT	233;231;232	A;G;T	202;202;202	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4560	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2998	151.9	1	SNP	p	S87R	0	.	.	259	261	AGT	606	608	AGT	233;231;232	A;G;T	202;202;202	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4560	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2998	151.9	1	SNP	p	S87W	0	.	.	259	261	AGT	606	608	AGT	233;231;232	A;G;T	202;202;202	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4560	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2998	151.9	1	SNP	p	S88P	0	.	.	262	264	TCC	609	611	TCC	235;238;240	T;C;C	207;208;210	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4078	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2554	159.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1562	1564	GGC	226;224;220	G;G;C	196;193;187	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3700	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2162	169.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1152	1154	GCA	231;229;231	G;C;A	202;201;205	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3700	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2162	169.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1155	1157	ATC	232;231;233	A;T;C	206;205;206	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3700	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2162	169.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1167	1169	GTG	234;236;234	G;T;G	211;213;211	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3700	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2162	169.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1167	1169	GTG	234;236;234	G;T;G	211;213;211	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3700	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2162	169.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1671	1673	ACC	209;211;212	A;C;C	183;185;185	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3700	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2162	169.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1725	1727	GCG	198;196;198	G,A;C,G;G	169,1;149,2;161	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3700	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2162	169.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1725	1727	GCG	198;196;198	G,A;C,G;G	169,1;149,2;161	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3700	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2162	169.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1848	1850	GGC	180;181;178	G;G,A;C,T	161;162,1;160,2	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3700	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2162	169.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1857	1859	GGC	186;184;183	G,A;G;C	164,1;164;160	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3700	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2162	169.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1875	1877	CTG	164;165;166	C,G;T,G;G	123,7;109,1;121	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5254	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3135	167.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1630	1632	CCG	179;179;177	C,A;C;G	158,1;167;159	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2152	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1759	121.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	573	573	C	144	C	128	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	254	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	483	26.9	0	.	p	.	0	M18T	NONSYN	52	54	ATG	356	358	ACG	72;70;68	A;C;G	58;58;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	254	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	483	26.9	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	398	400	CAA	38;36;34	C;A;A	32;31;29	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	254	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	483	26.9	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	404	406	TAC	26;24;23	T;A;C	25;22;23	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2312	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1483	154.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	416	418	GAA	193;195;193	G,T;A;A	175,1;178;175	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2312	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1483	154.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	704	706	GAT	244;245;247	G;A;T	216;217;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2312	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1483	154.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	827	829	TCA	180;177;180	T;C;A	159;156;159	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2312	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1483	154.8	0	.	p	.	0	K207E	NONSYN	619	621	AAA	923	925	GAA	165;165;166	G;A;A	147;148;150	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2312	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1483	154.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	956	958	GTC	176;172;175	G;T;C	157;152;152	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2312	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1483	154.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	968	970	TCT	166;163;161	T;C,T;T	154;150,1;148	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2312	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1483	154.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1286	1288	GCA	186;187;187	G;C;A	170;170;169	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2312	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1483	154.8	1	SNP	p	G120K	1	.	.	358	360	AAG	662	664	AAG	228;231;231	A;A;G	208;211;211	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2312	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1483	154.8	1	SNP	p	D121N	0	.	.	361	363	GAC	665	667	GAC	232;231;228	G;A;C	212;211;206	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2312	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1483	154.8	1	SNP	p	A121D	1	.	.	361	363	GAC	665	667	GAC	232;231;228	G;A;C	212;211;206	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	294	porB3	990	116	92.24	porB3.l15.c30.ctg.1	483	25.0	0	.	p	.	0	M18T	NONSYN	52	54	ATG	356	358	ACG	66;64;61	A;C;G	53;53;50	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	294	porB3	990	116	92.24	porB3.l15.c30.ctg.1	483	25.0	0	.	p	.	0	T29A	NONSYN	85	87	ACC	389	391	GCC	59;56;54	G;C;C	47;46;44	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	294	porB3	990	116	92.24	porB3.l15.c30.ctg.1	483	25.0	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	398	400	CAA	35;33;31	C;A;A	29;28;26	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	294	porB3	990	116	92.24	porB3.l15.c30.ctg.1	483	25.0	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	404	406	TAC	23;21;20	T;A;C	22;19;20	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8724	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4757	182.8	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1968	1970	AAT	196;199;199	A;A,G;T,G	172;175,1;172,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	898	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	904	97.8	1	SNP	p	V57M	1	.	.	169	171	ATG	468	470	ATG	195;197;200	A;T;G	175;176;178	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
